Jennison Associates LLC Novo Nordisk A S Transaction History
Jennison Associates LLC
- $160 Billion
- Q3 2024
A detailed history of Jennison Associates LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Jennison Associates LLC holds 20,195,957 shares of NVO stock, worth $1.72 Billion. This represents 1.5% of its overall portfolio holdings.
Number of Shares
20,195,957
Previous 21,220,641
4.83%
Holding current value
$1.72 Billion
Previous $3.03 Billion
20.61%
% of portfolio
1.5%
Previous 1.95%
Shares
23 transactions
Others Institutions Holding NVO
# of Institutions
1,957Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Morgan Stanley New York, NY14.4MShares$1.22 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.22 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.13 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.04 Billion3.76% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.58MShares$815 Million0.13% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $192B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...